Shockwave Medical, Inc.SWAV

Market cap
P/E ratio
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Net income (loss)-51-66-9216147
Depreciation and amortization---510
Loss from equity method investment---6-2-2
Stock-based compensation410274573
Non-cash lease expense---33
Amortization of premium and discount on available-for-sale securities1-0-1012
Loss on write down of fixed assets00000
Loss on extinguishment of debt----1-1
Deferred income taxes----9715
Amortization of debt issuance costs01112
Foreign currency remeasurement----11
Accounts receivable54263342
Inventory717123031
Prepaid expenses and other current assets11243
Other assets-00-034
Accounts payable1-1220
Accrued and other current liabilities84221233
Lease liabilities----22
Increase (Decrease) in Income Taxes Payable----2
Net cash provided by operating activities-48-7115118196
Purchase of available-for-sale securities119168117138747
Proceeds from maturities of available-for-sale securities6472156101247
Purchase of property and equipment412122531
Payments to Acquire Businesses, Net of Cash Acquired----94
Net cash (used in) provided by investing activities-60-10726-62-626
Payments of taxes withheld on net settled vesting of restricted stock units-1800
Proceeds from debt financing----80
Proceeds from Convertible Debt----730
Purchases of capped calls related to convertible debt----96
Payment For Assumed Warrant Liabilities----16
Proceeds from stock option exercises24331
Proceeds from issuance of common stock under employee stock purchase plan---46
Repayments of long-term debt---18105
Net cash provided by (used in) financing activities20890-213600
Effect of exchange rate changes on cash and cash equivalents----11
Net increase in cash, cash equivalents and restricted cash100-893967172
Interest paid11112
Income tax paid00028
Right-of-use asset obtained in exchange for lease liability702280
Capital Expenditures Incurred but Not yet Paid02264
Equity method investment obtained in exchange for related party contract liability--12--